BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 29307832)

  • 1. MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7.
    Zhu J; Zhang Z; Zhang Y; Li W; Zheng W; Yu J; Wang B; Chen L; Zhuo Q; Chen L; Zhang J; Liu J
    Biochem Biophys Res Commun; 2018 Jan; 496(1):176-183. PubMed ID: 29307832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
    Xie X; Dou CY; Zhou Y; Zhou Q; Tang HB
    Dig Dis Sci; 2021 Jun; 66(6):1928-1939. PubMed ID: 32648079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells.
    Tu X; Zheng X; Li H; Cao Z; Chang H; Luan S; Zhu J; Chen J; Zang Y; Zhang J
    Toxicol Sci; 2015 Jul; 146(1):157-69. PubMed ID: 25912033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis.
    Kim J; Kang W; Kang SH; Park SH; Kim JY; Yang S; Ha SY; Paik YH
    Sci Rep; 2020 Dec; 10(1):21018. PubMed ID: 33273492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
    Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
    Yu F; Fan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice.
    Lei XF; Fu W; Kim-Kaneyama JR; Omoto T; Miyazaki T; Li B; Miyazaki A
    J Hepatol; 2016 Jan; 64(1):110-7. PubMed ID: 26334580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7.
    Zhou QY; Yang HM; Liu JX; Xu N; Li J; Shen LP; Zhang YZ; Koda S; Zhang BB; Yu Q; Chen JX; Zheng KY; Yan C
    Parasit Vectors; 2021 Sep; 14(1):472. PubMed ID: 34521449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7.
    Yu F; Guo Y; Chen B; Dong P; Zheng J
    Lab Invest; 2015 Jul; 95(7):781-9. PubMed ID: 25915722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
    Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-195 Activates Hepatic Stellate Cells In Vitro by Targeting Smad7.
    Song LY; Ma YT; Wu CF; Wang CJ; Fang WJ; Liu SK
    Biomed Res Int; 2017; 2017():1945631. PubMed ID: 28929107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rebalancing TGF-β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis.
    Yang Y; Sun M; Li W; Liu C; Jiang Z; Gu P; Li J; Wang W; You R; Ba Q; Li X; Wang H
    Clin Transl Med; 2021 Jul; 11(7):e410. PubMed ID: 34323416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
    Wu SM; Li TH; Yun H; Ai HW; Zhang KH
    Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.
    Hyun J; Wang S; Kim J; Rao KM; Park SY; Chung I; Ha CS; Kim SW; Yun YH; Jung Y
    Nat Commun; 2016 Mar; 7():10993. PubMed ID: 27001906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-142-3p blocks TGF-β-induced activation of hepatic stellate cells through targeting TGFβRI.
    Yang X; Dan X; Men R; Ma L; Wen M; Peng Y; Yang L
    Life Sci; 2017 Oct; 187():22-30. PubMed ID: 28823564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
    Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y
    Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.
    Ji F; Wang K; Zhang Y; Mao XL; Huang Q; Wang J; Ye L; Li Y
    J Cell Biochem; 2019 Mar; 120(3):4573-4581. PubMed ID: 30368874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
    Lakner AM; Steuerwald NM; Walling TL; Ghosh S; Li T; McKillop IH; Russo MW; Bonkovsky HL; Schrum LW
    Hepatology; 2012 Jul; 56(1):300-10. PubMed ID: 22278637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes.
    Zhu J; Luo Z; Pan Y; Zheng W; Li W; Zhang Z; Xiong P; Xu D; Du M; Wang B; Yu J; Zhang J; Liu J
    J Cell Physiol; 2019 Jun; 234(6):9698-9710. PubMed ID: 30362572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.